Journal of the American Chemical Society · 2025 · 27 citations · 25 references
PharmacyChemistryMedicinal ChemistryCatalysisOrganic ChemistrySynthetic Medicinal ChemistryDiversity-oriented SynthesisHeterocycle SynthesisAsymmetric Heterocycle SynthesisAsymmetric SynthesisCatalytic SelectivityEnantioselective CatalysisTransition-metal-catalyzed FunctionalizationTransition-metal-catalyzed Heterocycle Synthesis
Currently, most sulfoximine clinical candidates feature both S -aryl and S -alkyl substituents. The asymmetric synthesis of these compounds typically relies on oxidizing corresponding enantioenriched sulfilimines. Herein, we describe an effective catalytic system comprising CuI and an azabicyclo[2.2.1] carboxylic acid-derived amide ligand. This system enables the highly enantioselective coupling of S -alkyl sulfenamides with (hetero)aryl iodides to afford aryl alkyl sulfilimines. A wide range of functionalized (hetero)aryl iodides and S -alkyl sulfenamides are compatible under the reaction conditions, providing an attractive approach for assembling enantioenriched aryl alkyl sulfilimines. The utility of this method is demonstrated by the gram-scale asymmetric synthesis of clinical candidate TNG 260 and the formal asymmetric synthesis of three additional drug candidates.
25